Based on the 2013
version, this update Report provides detailed analysis on Chinese government
policies about dialysis industry and the relevant effect in recent three years,
and conducts in-depth research about dialysis industry segmentations. Moreover,
it analyzes Chinese private-owned hemodialysis services. In the aspect of
enterprises, this update Report not only updates the latest information about
the key enterprises listed in 2013 version, but also adds the information about
some enterprises who intend to enter into this industry. This update Report
reflects an overall development situation of China's dialysis industry and
provides references for investors and entrepreneurs.
In China, hemodialysis
treatment has gained a wide popularity. By the end of 2013, the number of
dialysis centers has amounted to 3637, contributing a make scale of CNY 14.4
billion, in which, hemodialysis was CNY 11.5 billion, and peritoneal dialysis
was CNY 2.9 billion.
Complete report is
available at: http://www.radiantinsights.com/research/research-and-development-prospect-of-china-dialysis-market-2014-2018
Foreign enterprises,
such as, Germany Fresenius, Japan Nikkiso and Asahi Kasei, have dominated
China's dialysis market. Chinese enterprises mainly are engaged in the
production of dialysis tubing or dialysate and other low technology content
products. And few Chinese enterprises are specialized in manufacturing dialysis
machines and dialyzers or other high end products. Now the situation improved a
little, Chinese enterprise Weigao has led China's hemodialysis machines and
dialyzers manufacture, and Chinese enterprise Huaren Pharma has led China's
peritoneal dialysis industry.
By the end of May 2014,
rural residence critical illness insurance program has already covered over 50%
counties (cities and districts) in whole China. And in Shandong, Tianjin,
Jilin, Gansu, and Qinghai, and some other cities and provinces, the critical
illness insurance program is in full swing, and the provincial government has
implemented the overall planning in each administrative region. Huidian
Research believes that along with the gradual implementation of critical
illness program in China, more and more ESRD (End Stage Renal Disease) patients
will enjoy the insurance guarantee. Therefore, China's dialysis industry is
entering into golden development stage.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment